Scinovex
articleTop 1% cited

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

Archives of Neurology · 2011 · Vol. 69(1) · pp. 29–29
Suzanne Craft

Abstract

These results support longer trials of intranasal insulin therapy for patients with amnestic mild cognitive impairment and patients with AD. Trial Registration clinicaltrials.gov Identifier: NCT00438568.

Neurological Disorders and TreatmentsGlaucoma and retinal disordersNeurological Disease Mechanisms and TreatmentsMedicineMontreal Cognitive AssessmentInsulinInternal medicineClinical Dementia RatingPlaceboDementiaAlzheimer's diseasePhysical therapyDisease

MeSH terms

Administration, IntranasalAgedAlzheimer DiseaseDose-Response Relationship, DrugDouble-Blind MethodFemaleFollow-Up StudiesHospitals, VeteransHumansHypoglycemic AgentsImmunoassayInsulinMaleNeuropsychological TestsPeptide Fragments

Funding

  • U.S. Department of Veterans Affairs
  • Nancy and Buster Alvord Endowment
  • University of Washington
  • NIH Clinical Center
Citations
1,217
FWCI
61.93
field-weighted impact
References
33
Percentile
100%
vs. same field & year
Citations per year
References
A new rating scale for Alzheimer's disease
American Journal of Psychiatry · 1984 · 4,157 citations
A Three-Dimensional Statistical Analysis for CBF Activation Studies in Human Brain
Journal of Cerebral Blood Flow & Metabolism · 1992 · 2,053 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.